当归拈痛汤对类风湿性关节炎作用机理及配伍的实验研究
|
摘要
类风湿性关节炎(RA)是当前世界范围内严重威胁公众健康的慢性疾病之一。其病因繁多,发病机制复杂。当归拈痛汤是临床治疗RA的有效方剂。本课题以当归拈痛汤为研究对象,以RA为研究切入点,对该方抗炎免疫作用及治疗RA的作用机理进行了较为深入的研究。并将该方进行了拆方配伍研究,探讨了蠲痹法和扶正法在当归拈痛汤中的配伍意义。
目的:研究当归拈痛汤对RA的作用机理及配伍意义。
方法:以佐剂性关节炎大鼠(AA)作为实验模型,以雷公藤多甙片为阳性对照药,进行拆方研究(分为当归拈痛汤全方组、蠲痹组、扶正组),观察大鼠足跖肿胀度、压力耐痛值、胸腺、脾脏指数,以及关节内病理组织学变化;通过对血清相关炎性细胞因子、红细胞天然免疫指标的检测和滑膜组织相关的粘附因子、血管内皮生长因子、基质金属蛋白酶、凋亡因子Fas/FasL mRNA表达,探讨了当归拈痛汤及其各个拆方组对AA大鼠的抗炎及免疫调节作用以及部分机理。
结果:(1)当归拈痛汤有明显的抗炎、镇痛、免疫调节作用,可显著抑制AA大鼠足跖肿胀及多发性关节炎,提高AA大鼠的压力耐痛值,改善AA大鼠的免疫器官指数,同时明显减轻病变关节滑膜炎症与增生、防止关节软骨及骨质的破坏。(2)当归拈痛汤通过抑制AA大鼠过高的炎性细胞因子TNF-a、IL-1分泌、提高大鼠红细胞天然免疫功能,而发挥抗炎和免疫调节作用。(3)在病变关节滑膜局部,当归拈痛汤能抑制AA大鼠滑膜细胞异常增高的ICAM-1的表达,从而抑制滑膜的炎症与增殖。(4)当归拈痛汤能下调滑膜组织中VEGF表达,减少血管新生,由此抑制血管翳的形成。(5)当归拈痛汤还可下调滑膜组织中MMP-3表达,防止软骨和软骨下骨的侵蚀。(6)当归拈痛汤可以促进凋亡因子Fas/FasL mRNA表达,改善AA大鼠的滑膜细胞凋亡障碍。
结论:当归拈痛汤具有多层次、多途径、多靶点的抗炎及免疫调节作用。当归拈痛汤的抗炎、免疫调节作用与其抑制炎性细
Rheumatoid arthritis (RA) is one of serious chronic diseases which threat public healthy in the world, the mechanism of outbreak is complicated. Dangguiniantong tang had a good effect to treat RA. This reseach carry on a deep study on anti-inflammation, immunity and treatment mechanism to RA of Dangguiniantong tang. By the decomposition and compatibility study, explored the meaning of juanbi method and fuzheng method in Dangguiniantong tang.Objective: study the mechanism of Dangguiniantong tang treat RA and the meaning of compatibility.Methods: take adjuvant induced arthritis rat as experiment model, treat with Dangguiniantong tang, each decomposition and TriPterygium Glycosides in different groups. Observe the swelling of arthritis, press-risisting index, thymus, spleen index , pathology change in arthritis, and the express of CK, ICAM-1, IL-1, VEGF, MMP, Fas/FasL mRNA, explore the anti-inflammation, immunity and partial treatment mechanism to RA of Dangguiniantong tang and it's decomposition.Results: (1)Dangguiniantong tang has obviously effect of anti-inflammation, inhibition swelling of arthritis, increase the perss-resisting index, it can also lighten the synovial inflammation and hyperplasia of lesion joints distinctly, and prevent the joint cartilage and bone from destruction. (2)Dangguiniantong tang can retain the excessive decimrter of TNF- a、 IL-1, improve the immunity function of RBC, so as to give play to anti-inflammation and immunity adjust. Juanbi method has good effect on anti-inflammation and fuzheng method has good effect at immunity adjust. (3) in locat joints, Dangguiniantong tang can retain the excessive express of ICAM-1, thus retain the inflammation and
proliferation of synovial tissue. (4).Dangguiniantong tang can decrease the express of VEGF in synovial tissue, drcrease the growth of new vessel, retain the form of pannus. (5) Dangguiniantong tang can decrease the express of MMP-3 in synocial tissue, prevent the destroy of bone and cartilage. (6) Dangguiniantong tang can increase the express of Fas/FasL mRNA, improve the disorder of PDD.Conclusions: Dangguiniantong tang has the effect of anti-inflammation and immunity adjust, they are related with inhibite expression of inflammation CK and improve the immunity function of RBC. By the way of adjusting the express of MMP-3, Fas/FasL mRNA, VEGF, ICAM-1 in synocial tissue, Dangguiniantong tang control the inflammation of synocial, and prevent the distory of bone and cartilage. Juanbi method has good effect at anti-inflammation, and fuzheng method has good effect at immunity adjust, they have good compatibility effect in whole prescribe.
目的:研究当归拈痛汤对RA的作用机理及配伍意义。
方法:以佐剂性关节炎大鼠(AA)作为实验模型,以雷公藤多甙片为阳性对照药,进行拆方研究(分为当归拈痛汤全方组、蠲痹组、扶正组),观察大鼠足跖肿胀度、压力耐痛值、胸腺、脾脏指数,以及关节内病理组织学变化;通过对血清相关炎性细胞因子、红细胞天然免疫指标的检测和滑膜组织相关的粘附因子、血管内皮生长因子、基质金属蛋白酶、凋亡因子Fas/FasL mRNA表达,探讨了当归拈痛汤及其各个拆方组对AA大鼠的抗炎及免疫调节作用以及部分机理。
结果:(1)当归拈痛汤有明显的抗炎、镇痛、免疫调节作用,可显著抑制AA大鼠足跖肿胀及多发性关节炎,提高AA大鼠的压力耐痛值,改善AA大鼠的免疫器官指数,同时明显减轻病变关节滑膜炎症与增生、防止关节软骨及骨质的破坏。(2)当归拈痛汤通过抑制AA大鼠过高的炎性细胞因子TNF-a、IL-1分泌、提高大鼠红细胞天然免疫功能,而发挥抗炎和免疫调节作用。(3)在病变关节滑膜局部,当归拈痛汤能抑制AA大鼠滑膜细胞异常增高的ICAM-1的表达,从而抑制滑膜的炎症与增殖。(4)当归拈痛汤能下调滑膜组织中VEGF表达,减少血管新生,由此抑制血管翳的形成。(5)当归拈痛汤还可下调滑膜组织中MMP-3表达,防止软骨和软骨下骨的侵蚀。(6)当归拈痛汤可以促进凋亡因子Fas/FasL mRNA表达,改善AA大鼠的滑膜细胞凋亡障碍。
结论:当归拈痛汤具有多层次、多途径、多靶点的抗炎及免疫调节作用。当归拈痛汤的抗炎、免疫调节作用与其抑制炎性细
Rheumatoid arthritis (RA) is one of serious chronic diseases which threat public healthy in the world, the mechanism of outbreak is complicated. Dangguiniantong tang had a good effect to treat RA. This reseach carry on a deep study on anti-inflammation, immunity and treatment mechanism to RA of Dangguiniantong tang. By the decomposition and compatibility study, explored the meaning of juanbi method and fuzheng method in Dangguiniantong tang.Objective: study the mechanism of Dangguiniantong tang treat RA and the meaning of compatibility.Methods: take adjuvant induced arthritis rat as experiment model, treat with Dangguiniantong tang, each decomposition and TriPterygium Glycosides in different groups. Observe the swelling of arthritis, press-risisting index, thymus, spleen index , pathology change in arthritis, and the express of CK, ICAM-1, IL-1, VEGF, MMP, Fas/FasL mRNA, explore the anti-inflammation, immunity and partial treatment mechanism to RA of Dangguiniantong tang and it's decomposition.Results: (1)Dangguiniantong tang has obviously effect of anti-inflammation, inhibition swelling of arthritis, increase the perss-resisting index, it can also lighten the synovial inflammation and hyperplasia of lesion joints distinctly, and prevent the joint cartilage and bone from destruction. (2)Dangguiniantong tang can retain the excessive decimrter of TNF- a、 IL-1, improve the immunity function of RBC, so as to give play to anti-inflammation and immunity adjust. Juanbi method has good effect on anti-inflammation and fuzheng method has good effect at immunity adjust. (3) in locat joints, Dangguiniantong tang can retain the excessive express of ICAM-1, thus retain the inflammation and
proliferation of synovial tissue. (4).Dangguiniantong tang can decrease the express of VEGF in synovial tissue, drcrease the growth of new vessel, retain the form of pannus. (5) Dangguiniantong tang can decrease the express of MMP-3 in synocial tissue, prevent the destroy of bone and cartilage. (6) Dangguiniantong tang can increase the express of Fas/FasL mRNA, improve the disorder of PDD.Conclusions: Dangguiniantong tang has the effect of anti-inflammation and immunity adjust, they are related with inhibite expression of inflammation CK and improve the immunity function of RBC. By the way of adjusting the express of MMP-3, Fas/FasL mRNA, VEGF, ICAM-1 in synocial tissue, Dangguiniantong tang control the inflammation of synocial, and prevent the distory of bone and cartilage. Juanbi method has good effect at anti-inflammation, and fuzheng method has good effect at immunity adjust, they have good compatibility effect in whole prescribe.
引文
[1] 张乃峥.中国风湿病学的建立与发展[J].中华内科杂志,1992,31(8):498
[2] 蒋明.加强类风湿关节炎的临床研究[J].中华医学杂志,1998,78(3):5-6
[3] 唐福林.加强对类风湿关节炎早期诊断的实验研究[J].中华风湿病学杂志.1998,2(1):4-5
[4] 陈龙全,陈斌.类风湿性关节炎的病因病机及其辨证分型[J].中医药学刊,2003,21(3):469-470
[5] 何永生, 张雪莲.类风湿性关节炎的中医病机探讨[J].浙江中西医结合杂志,2003,13(10):624-625
[6] 闫小萍,焦树德.旭痹三悟[J].中国医药学报,1993,8(5):49-51
[7] 李拥,周祖山,周承明.周承明对类风湿性关节炎病机的独特认识及其意义[J].湖北中医杂志,2000,22(7):4-5
[8] 刘健,郑志坚.类风湿性关节炎中医学病机探讨[J].中国中医基础医学杂志志,2001,7(9):13-14
[9] 何羿婷,付丽嫒,阎小萍.类风湿性关节炎中医证候分布规律的初步探讨[J].中国中医基础医学杂志,2004,10(1):26-28
[10] 周全,耿建国.浅谈类风湿性关节炎的病机演变规律及相应的治疗策略[J].陕西中医,2005,26(30):287
[11] 刘英.周海蓉.从毒探讨活动性类风湿性关节炎的发病机制[J].山东中医杂志,2003,22(7);390-392
[12] 周全,刘征堂.金实教授从湿论治类风湿性关节炎经验介绍[J].新中医,2005,37(1):21-22
[13] 朱建华.虫类药在类风湿关节炎中的应用[J].中国临床医生,2000,28(4):12
[14] 周学平,吴勉华.中医药治疗类风湿性关节炎的新观点[J].中国临床康复.2002,6(5):624-625
[15] 刘莉,魏晓燕.治痹八法[J].中医药信息,2001,18(3):74
[16] 焦树德.再谈尩痹的辨证论治[J].中医杂志,1997,(8):504
[17] 郭志刚.类风湿性关节炎证治体会[J].实用中医药杂志,2005,21(2):122-123.
[18] 张四方,朱伟光.防已黄芪汤治疗类风湿性关节炎近期疗效观察[J].中国医师杂志,2005,7(6):856-857
[19] 沈晓燕,陈纪藩.经方在类风湿性关节炎治疗中的灵活运用[J].中国中医基础医学杂志,2001,7(3):67-68.
[20] 朱良春.医学微言[M].北京:人民卫生出版社,1996:1
[21] 周学平,周仲瑛,等舒关冲剂治疗中晚期类风湿性关节炎的临床与实验研究[J].中国中西医结合杂志,1999,19(2):80-83
[22] 胡荫奇.风湿安冲剂治疗类风湿性关节炎临床研究[J].中国医药学报,2000,15(1):43
[23] 许峰,戴小明.章光华.四藤饮治疗类风湿性关节炎123例临床观察[J].中医杂志,2003,44(10):760-761.
[24] 张秋霞,葛爱华,张华伟.中西医结合治疗类风湿性关节炎100例临床观察[J].四川中医,2004,22(4)):28-29.
[25] 张占铸.中西医结合治疗类风湿性关节炎[J]. 实用中医内科杂志,2004,18(2):127-127.
[26] 刘洪波.中西医结合治疗类风湿性关节炎60例[J].陕西中医2003,24(3): 208-209.
[27] 胡大伟,刘沛霖.雷公藤与强的松药理作用的互补性[J].中国中西医结合杂志.1997,17(2):94-96
[28] 唐韬,赵敏奇,刘春城.温针治疗类风湿性关节炎58例[J].上海针灸杂志,2005,24(1):32
[29] 荣莉,伦新.蜂针治疗类风湿性关节炎的临床观察[J].中医外治杂志,2002,11(2):14
[30] 姚建,赵晓刚,王璐.中药汽疗雾化透皮法治疗类风湿性关节炎108例[J].中国中医药信息杂志,2004,11(8):728-729.
[31] 李金文,徐光华,陈炽祥等.热矿泥外敷结合辨证治疗类风湿性关节炎85例疗效观察[J].新中医,2003,35(1):23-24.
[32] 徐峰,白玉宾.痛痹贴治疗类风湿性关节炎临床疗效观察[J].中医药信息,2004,21(1):26
[33] 李先文,左祖英,张凤鸣,夏建萍.关节灵对小鼠体液免疫功能影响的实验研究[J].川北医学院学报,1999,14(6):14-15
[34] 郝饪,沈欣,邱全瑛.清热燥湿法对类风湿性关节炎治疗作用的实验研究[J].中国中医基础医学杂志,1997,3(1):32-34
[35] 李惠,金亚宏,原桂东,王素芬.逐痹胶囊对大鼠佐剂性关节炎的影响[J].中国中药杂志2005,30(7):551-555.
[36] 周学平,方泰惠,周玲玲,宋耀鸿,等.清络通痹颗粒治疗类风湿性关节炎的分子作用机理研究[J].中药药理与临床,2003,19(1):35-37
[37] 王从品,吴玉林.克湿灵治疗类风湿性关节炎的作用机制研究[J].中国中药杂志,2006,31(2):156-159
[38] 陈纪藩,刘清平.通痹灵对胶原诱导性关节炎大鼠滑膜组织血管内皮生长因子表达水平的影响[J].广州中医药大学学报,2003,20(1):4-7
[39] 冷南,张欣,樊春梅,等.类风湿性关节炎患者红细胞免疫功能的改变[J].第四军医大学学报,1994,15(4):290-292
[40] 胡晓蕙,汪涛,王洁,等.克痹Ⅱ号调节初发类风湿性关节炎患者然免疫的实验研究[J].中草药,2000,31(2):120-121.
[41] 张玲玲,魏伟,严尚学,等.木瓜苷对小鼠胶原性关节炎的预防作用及初步机制[J].中国药理学通报,2000,20(1):95-100
[42] 都晓春,刘漫虹,倪国成.痹痛清胶囊的主要药效学研究[J].长春中医学院学报,2002,18(4):38
[43] 李金祥,单友琴,王鑫国.通经蠲痹胶囊治疗类风湿性关节炎的实验研究[J].河北中医,2002,24(1):73-75
[44] 张立军,彭介寿,柴立民.历节合刺对佐剂性关节炎大鼠血液流变学的影响[J].中国中医基础医学杂志,2001,22(4):250
[45] 唐照亮,宋小鸽,章复清,等.艾灸对关节炎大鼠抗炎消肿作用及细胞因子、自由基影响[J].安徽中医学院学报,2001,20(5):34-37.
[46] 李博萍,潘竞锵,肖柳英,等.加味六味地黄汤对大鼠佐剂性关节炎的作用及机制研究[J].中医研究,2005,18,(6):16-18
[47] 陈纪藩,叶柳忠,陈光星,等.通痹灵对CIA大鼠关节软骨病变影响的实验研究[J].中国中医基础医学杂志,2003,9(5):33-35
[48] 陈灏珠.实用内科学[M].人民卫生出版社,2001,10:2318
[49] 潘正论,张源潮.中国内地人群类风湿关节炎与HLA-DRB 1共同表位基因关联性的Meta分析[J].中华风湿病学杂志,2004,8(11):662
[50] 赵岩,董怡,唐福林,等.HLA-DRB 1基因与我国北方类风湿关节炎的关系[J].中华内科杂志,1997,36(2):112
[51] 杜平.现代临床病毒学[M].北京:人民军医出版社,513.
[52] 张悦,王惠萱,杨光辉等.类风湿关节炎患者EB病毒感染及Th细胞激活的免疫学分析[J].现代检验医学杂志,2006,21(1):66-67
[53] 费克香,晏年春.类风湿性关节炎与T淋巴细胞研究[J].日本医学介绍,2000.21(9):427
[54] 李霞,孙健,范成明.细胞因子与类风湿关节炎[J].大连大学学报,2000,21(4):102
[55] 路秀英.免疫细胞、细胞因子及其抑制物在类风湿性关节炎发生发展中的作用[J].国外医学免疫学分册,1993,4:183-187.
[56] William RA, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoidarthritis. Arthritis Rheum. 1990, 33(3): 305-315
[57] Tyler JA. Articular cartilage cultured with catabilin(pig IL-1) Syntheses a decreased number of normal proteoglycan moleeules. Biochem J. 1985, 227: 869-878
[58] Gearing DP. The IL-6 signil transducer, gp130: An oncostatin M receptor and affinityconverter for the IL-6 receptor. Science. 1992, 255: 1434-1437
[59] Yin T. Involvement of IL-6 signal transducergp130 in IL-1 1-mediated signal transduction. J Immunol. 1993, 151: 2555-2561
[60] Henderson B, Pettipher ER. Art hritogenic actions of recombinant IL-I and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in rive. Clin Exp Immunol, 1989. 75(2): 306-310
[61] 郭峰.血液免疫学研究[M].上海:第二军医大学出版社,1998,4
[62] Siegel I, Liu TL, GleicherN. The red cell Immune system. Lancet, 1981, 2: 8246
[63] 时庆,韩辉,韩振霞.红细胞免疫检测的临床评价[J].中国实验临床免疫,1999,10(3):145-149
[64] 陈国强,张德成.红细胞C3b受体研究的新进展[J].中国免疫学杂志,1991,(6):8
[65] 郭峰,钱宝华,张乐之.现代红细胞免疫学[M].上海:第二军医大学出版社,2002,1-113.
[66] 余曙光,郝亮,宋开源,等.艾灸对类风湿关节炎大鼠血清ICAM-1的影响[J].中国针灸,2002,22(10):690-692.
[67] Paleoog EM, Angiogenesis. aeritical process in the pathogenesis of RA arole for VEGF Br J Rheumatol, 1996, 35: 917
[68] 裴瑞卿.基质金属蛋白酶家族介绍[J].中国生物化学与分子生物学报,2001,17(1):1-6.
[69] 赵志玲.基质金属蛋白酶及其抑制剂与类风湿性关节炎的研究进展[J].解放军药学学报,2005,21,(1):54-56
[70] 任洁,齐义成.类风湿性关节炎与细胞凋亡[J].天津医药,2004,32(4):255
[71] 周静,周桂琴,肖诚,等.基质金属蛋白酶MAPKS途径在类风湿性关节炎发病中的作用[J].中国中医基础医学杂志,2004,10(6):78
[72] Clio R, BeatriceA, Jean M J, et al. Matrix metalloproteinase 3 serumlevels are correlated with diseaseactivity and predietelinieal responseinrhed matoidarthritis[J]. J Rheum, 2000, 27(4): 888.
[73] 柴可夫.类风湿性关节炎[M].北京:科学技术文献出版,2000年版,18-21
[74] 浅原弘嗣·他 诊断治疗,1997,85(4):608
[75] KoushiFujisawa. HiroshiAsahaia. Kazu yoshiOkamoto. etal Thera -Peutie effect of the anti-fas antibody on arlhritis in HTLV-1 tax. tlansgeniemiee. JCihlnvest1996, 98: 271-278
[76] LinZ. XuX, HsaHG etalCll-D C, AdTRAILcellgenethemPy inbi-h its hfiltration of Cll-reative Tcells andCll induced arthritisJClinInvest 2003, 11: 1332-1341
[77] MatsnoH, YudohK, NakazawaF, etal Antirheumatic effects of hu-manized an ti-Fas monoclonal antibody inhuman rheumatoidarlhritis/SCIDmousechiera Jrheumato12002, 29: 1609-1614
[78] Chin JE, Winterrowd GE, Krzesicki RF, et al. Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule-1 and HLA-class Ⅰ and class Ⅱ antigens in rheumatoid synovial fibroblasts. Arthritis Rheum, 1990, 33: 1776-1786.
[79] 张文.粘附分子在类风湿关节炎中的作用[J].中华风湿病学杂志,1998,2(1):51
[80] 梁文同,刘风珍,宋胜利,等.类风湿性关节炎(RA)患者血清可溶性细胞间粘附分子-1 测定与核素骨显像相关性研究[J].中华临床与卫生,2004,3(1):8-10
[81] Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease-Nat Med1995, 1: 27-34
[79] Clauss, M, M. Gerlach, H. Gerlach, et al. Vascular permeability factor, a tumor-derived ploypeptide that induces endothelial cells and monocyte procoagulant activity and promotes monocyte migration, J Exp Med 1990, 164: 470-477
[83] 敖桂珍,张玉彬,张奕华.新型非甾体抗炎药作用靶环氧酶-2研究进展[J].中国新药杂志,2001,10(7):492-496
[84] 张新梅.类风湿性关节炎免疫治疗研究进展[J].医学综述,2004,10(2):115-117
[85] 刘或,韩星海,孟济明等.生物制剂在类风湿关节炎中的应用[J].中华风湿病学杂志,2003,7(5):300-301
[86] 赵延红.生物制荆在RA治疗中的应用[J].陕西中医学院学报,2004,27(2):69
[87] 严桂民.类风湿关节炎的基因治疗[J].中国新医药,2003,2(8):47
[88] 鲍春德.类风湿性关节炎治疗的现状及展望[J].上海医学,2003,26(7):449
[89] 徐叔云,卞如濂.陈修药理实验方法学[M].北京:人民卫生出版社,1991,723
[90] 张钧田.现代药理实验方法[M].北京:北京医科大学中国协和医科大学联合出版社,1998,1383.
[91] 郭峰,张励力.用C3b致敏醉母菌测定血清免疫复合物[J].上海免疫学杂志,1982,2(2):32
[92] Jacobson PB, Borgan SJ, Wilcox D M et al. A new spin on an old model: In viva evaluation of sense progression by magnetic reso-nance imaging with respect to standard inflammatory parametersand histopathology in the adjuvant arthritic rat. Arth tis Rheum, 1999, 42(10): 2060-73
[93] 吕爱平.类风湿关节炎中西医结合应用基础研究[M].北京:中医古籍出版社,1999,23
[94] 王绪辉.肢体痹证的造模方法[J].上海中医药杂志,1986,(3):3-5
[95] Easset RE, Hildebrand AR, Angelo RA, et al. Measure merit of radiographic changes in adjuv ant-induced arthritis in its by quantitative image analysis. Arthritis Rjeurr, 1995, 38: 129
[96] 许赤多,戴冽,汤美安等.大鼠佐剂性关节炎的诱导及观察指标比较[J].中国免疫学杂志,2002,18(2):140-141
[97] 陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1993,第一版.
[98] 王一涛,杨奎,王家葵,等.羌活的药理学研究[J].中药药理与临床,1996(4):12-15.
[99] 万尧德,何光星,胡菊英,等.茵陈素解热作用的研究,药学通报[J].1987,22(10):590-593
[100] 田代华.实用中药辞典[M].北京:人民卫生出版社,2002.1279.
[101] 钱信忠.中国本草彩色图鉴[M].常用中药篇(上卷)北京:人民卫生出版社, 1995, 99,153,166,254
[102] 董丽萍.葛根对免疫机制的作用[J].中国药理学报,1998,19(4):339.
[103] 蔡仙德,谭剑萍.黄琴贰对小鼠体液免疫功能影响[J].南京铁道医学院学报,1995,14(3):151-153
[104] 中华人民共和国药政管理局.现代实用本草[M].北京:人民卫生出版社,1999,248
[105] 骆和生,罗鼎辉.免疫中药学[M].北京:北京医科大学、中国协和医科大学联合出版社,1999,281
[106] 陈兰英,陈奇.中药复方药理研究方法进展[J].中国实验方剂学杂志,1999,5(3):62-64.
[107] 贺新怀,席孝贤.中医药免疫学[M].北京:人民军医出版社,2002,40.
[108] CalvinoB, CrePon— Bernard MO, LeBars D. Parallel clinical and behavioural studies of adjuvant — induced arthritis in the rat: Possible relationship with, "chronic pain", Behavioural Brain Research, 1987, 24(1): 11-19
[109] Niki Y, Ya mada H, Seki S, et al. Macrophage and neutrophildomi-nant arthritis in human IL-1 alpha trans genic mice. J Clin Invest, 2001, 107: 1127-1135.
[110] Siegel, TheRedCellImmuneSystem[M]. Lancet, 1981, 2: 556.
[111] 刘景田,张洁.红细胞免疫学[M].西安:陕西科学技术出版社,1995,11
[112] 张乃峥.临床风湿病学[M].北京:人民卫生出版社,1997,129-130
[113] Gearing A, Newman F: Circulating adhesion molecules in disease. Immunology Today. 1999, 14: 506-512
[114] S AOKI, Soluble intercellular adhesion molecule- 1(ICAM-1)antigen in Patiente- with rheumatoid arthritis. Stand J Immunoi, 1993, 38: 485-90
[115] Fava RA, Olsen NJ, Spencer-Green G, Vascular permeability factor/endothelial growth factor(VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994, 180:341
[116] 王建华,吴岳篙,徐卫东,等.血管内皮生长因子在大鼠实验性关节炎模型中表达的动态观察[J].中华风湿病学杂志,2002,6(1):43.
[117] synovial, fibroblasts, that digests connective tissue matrix components. J BiolChen1986, 261: 142, 45-55
[118] Zucker S, Hymowitzm, Conner c, et al. Measurement of matrix metanlloproteinases andtissue in hibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. 1999, 878: 212-27
[119] Posthumus MD, Limburg PC, Westra J, etal. Serum matrix metalloproteinase 3 levels during treatment with sulfassalazine or combination of methotrexate and sulfasalazine in patientswith early rheumatoid arthritis. J Rheumatol, 2002, 29: 883-9
[120] Konttinen YT, AinolaM, VallealaH, et al.. Analysis of 16 different matrix metalloProtelnases (MMP-1 to MMP-20)in the synovial membrane: differeniProfilesintraumaandtheUInatOid artllritis Ann Rheum Dis 1999, 58: 691-7
[121] 蒋明,朱立平,林孝义.风湿病学(上册)[M].北京:科学出版社,1995,815-819
[122] Nakajima T, Aono Hjiasmuma TApoptosis and functional Fas antigen in rheumatoid artbtitiis synoviocytes. Arthritis Rleurm1995, 38, 485-491.
[123] 郭磊.细胞凋亡在自身免疫发病机制中的作用[J].国外医学免疫学分册,1999,22(1):17-21
[124] 郑勇,袁泉.细胞凋亡基因fas的研究进展[J].国外医学免疫学分册,1996,19(3):131-135
[125] 孙红胜,陈昀,庞新强,等.类风湿关节炎细胞凋亡研究进展[J].中华风湿病学杂志,2000,
[2] 蒋明.加强类风湿关节炎的临床研究[J].中华医学杂志,1998,78(3):5-6
[3] 唐福林.加强对类风湿关节炎早期诊断的实验研究[J].中华风湿病学杂志.1998,2(1):4-5
[4] 陈龙全,陈斌.类风湿性关节炎的病因病机及其辨证分型[J].中医药学刊,2003,21(3):469-470
[5] 何永生, 张雪莲.类风湿性关节炎的中医病机探讨[J].浙江中西医结合杂志,2003,13(10):624-625
[6] 闫小萍,焦树德.旭痹三悟[J].中国医药学报,1993,8(5):49-51
[7] 李拥,周祖山,周承明.周承明对类风湿性关节炎病机的独特认识及其意义[J].湖北中医杂志,2000,22(7):4-5
[8] 刘健,郑志坚.类风湿性关节炎中医学病机探讨[J].中国中医基础医学杂志志,2001,7(9):13-14
[9] 何羿婷,付丽嫒,阎小萍.类风湿性关节炎中医证候分布规律的初步探讨[J].中国中医基础医学杂志,2004,10(1):26-28
[10] 周全,耿建国.浅谈类风湿性关节炎的病机演变规律及相应的治疗策略[J].陕西中医,2005,26(30):287
[11] 刘英.周海蓉.从毒探讨活动性类风湿性关节炎的发病机制[J].山东中医杂志,2003,22(7);390-392
[12] 周全,刘征堂.金实教授从湿论治类风湿性关节炎经验介绍[J].新中医,2005,37(1):21-22
[13] 朱建华.虫类药在类风湿关节炎中的应用[J].中国临床医生,2000,28(4):12
[14] 周学平,吴勉华.中医药治疗类风湿性关节炎的新观点[J].中国临床康复.2002,6(5):624-625
[15] 刘莉,魏晓燕.治痹八法[J].中医药信息,2001,18(3):74
[16] 焦树德.再谈尩痹的辨证论治[J].中医杂志,1997,(8):504
[17] 郭志刚.类风湿性关节炎证治体会[J].实用中医药杂志,2005,21(2):122-123.
[18] 张四方,朱伟光.防已黄芪汤治疗类风湿性关节炎近期疗效观察[J].中国医师杂志,2005,7(6):856-857
[19] 沈晓燕,陈纪藩.经方在类风湿性关节炎治疗中的灵活运用[J].中国中医基础医学杂志,2001,7(3):67-68.
[20] 朱良春.医学微言[M].北京:人民卫生出版社,1996:1
[21] 周学平,周仲瑛,等舒关冲剂治疗中晚期类风湿性关节炎的临床与实验研究[J].中国中西医结合杂志,1999,19(2):80-83
[22] 胡荫奇.风湿安冲剂治疗类风湿性关节炎临床研究[J].中国医药学报,2000,15(1):43
[23] 许峰,戴小明.章光华.四藤饮治疗类风湿性关节炎123例临床观察[J].中医杂志,2003,44(10):760-761.
[24] 张秋霞,葛爱华,张华伟.中西医结合治疗类风湿性关节炎100例临床观察[J].四川中医,2004,22(4)):28-29.
[25] 张占铸.中西医结合治疗类风湿性关节炎[J]. 实用中医内科杂志,2004,18(2):127-127.
[26] 刘洪波.中西医结合治疗类风湿性关节炎60例[J].陕西中医2003,24(3): 208-209.
[27] 胡大伟,刘沛霖.雷公藤与强的松药理作用的互补性[J].中国中西医结合杂志.1997,17(2):94-96
[28] 唐韬,赵敏奇,刘春城.温针治疗类风湿性关节炎58例[J].上海针灸杂志,2005,24(1):32
[29] 荣莉,伦新.蜂针治疗类风湿性关节炎的临床观察[J].中医外治杂志,2002,11(2):14
[30] 姚建,赵晓刚,王璐.中药汽疗雾化透皮法治疗类风湿性关节炎108例[J].中国中医药信息杂志,2004,11(8):728-729.
[31] 李金文,徐光华,陈炽祥等.热矿泥外敷结合辨证治疗类风湿性关节炎85例疗效观察[J].新中医,2003,35(1):23-24.
[32] 徐峰,白玉宾.痛痹贴治疗类风湿性关节炎临床疗效观察[J].中医药信息,2004,21(1):26
[33] 李先文,左祖英,张凤鸣,夏建萍.关节灵对小鼠体液免疫功能影响的实验研究[J].川北医学院学报,1999,14(6):14-15
[34] 郝饪,沈欣,邱全瑛.清热燥湿法对类风湿性关节炎治疗作用的实验研究[J].中国中医基础医学杂志,1997,3(1):32-34
[35] 李惠,金亚宏,原桂东,王素芬.逐痹胶囊对大鼠佐剂性关节炎的影响[J].中国中药杂志2005,30(7):551-555.
[36] 周学平,方泰惠,周玲玲,宋耀鸿,等.清络通痹颗粒治疗类风湿性关节炎的分子作用机理研究[J].中药药理与临床,2003,19(1):35-37
[37] 王从品,吴玉林.克湿灵治疗类风湿性关节炎的作用机制研究[J].中国中药杂志,2006,31(2):156-159
[38] 陈纪藩,刘清平.通痹灵对胶原诱导性关节炎大鼠滑膜组织血管内皮生长因子表达水平的影响[J].广州中医药大学学报,2003,20(1):4-7
[39] 冷南,张欣,樊春梅,等.类风湿性关节炎患者红细胞免疫功能的改变[J].第四军医大学学报,1994,15(4):290-292
[40] 胡晓蕙,汪涛,王洁,等.克痹Ⅱ号调节初发类风湿性关节炎患者然免疫的实验研究[J].中草药,2000,31(2):120-121.
[41] 张玲玲,魏伟,严尚学,等.木瓜苷对小鼠胶原性关节炎的预防作用及初步机制[J].中国药理学通报,2000,20(1):95-100
[42] 都晓春,刘漫虹,倪国成.痹痛清胶囊的主要药效学研究[J].长春中医学院学报,2002,18(4):38
[43] 李金祥,单友琴,王鑫国.通经蠲痹胶囊治疗类风湿性关节炎的实验研究[J].河北中医,2002,24(1):73-75
[44] 张立军,彭介寿,柴立民.历节合刺对佐剂性关节炎大鼠血液流变学的影响[J].中国中医基础医学杂志,2001,22(4):250
[45] 唐照亮,宋小鸽,章复清,等.艾灸对关节炎大鼠抗炎消肿作用及细胞因子、自由基影响[J].安徽中医学院学报,2001,20(5):34-37.
[46] 李博萍,潘竞锵,肖柳英,等.加味六味地黄汤对大鼠佐剂性关节炎的作用及机制研究[J].中医研究,2005,18,(6):16-18
[47] 陈纪藩,叶柳忠,陈光星,等.通痹灵对CIA大鼠关节软骨病变影响的实验研究[J].中国中医基础医学杂志,2003,9(5):33-35
[48] 陈灏珠.实用内科学[M].人民卫生出版社,2001,10:2318
[49] 潘正论,张源潮.中国内地人群类风湿关节炎与HLA-DRB 1共同表位基因关联性的Meta分析[J].中华风湿病学杂志,2004,8(11):662
[50] 赵岩,董怡,唐福林,等.HLA-DRB 1基因与我国北方类风湿关节炎的关系[J].中华内科杂志,1997,36(2):112
[51] 杜平.现代临床病毒学[M].北京:人民军医出版社,513.
[52] 张悦,王惠萱,杨光辉等.类风湿关节炎患者EB病毒感染及Th细胞激活的免疫学分析[J].现代检验医学杂志,2006,21(1):66-67
[53] 费克香,晏年春.类风湿性关节炎与T淋巴细胞研究[J].日本医学介绍,2000.21(9):427
[54] 李霞,孙健,范成明.细胞因子与类风湿关节炎[J].大连大学学报,2000,21(4):102
[55] 路秀英.免疫细胞、细胞因子及其抑制物在类风湿性关节炎发生发展中的作用[J].国外医学免疫学分册,1993,4:183-187.
[56] William RA, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoidarthritis. Arthritis Rheum. 1990, 33(3): 305-315
[57] Tyler JA. Articular cartilage cultured with catabilin(pig IL-1) Syntheses a decreased number of normal proteoglycan moleeules. Biochem J. 1985, 227: 869-878
[58] Gearing DP. The IL-6 signil transducer, gp130: An oncostatin M receptor and affinityconverter for the IL-6 receptor. Science. 1992, 255: 1434-1437
[59] Yin T. Involvement of IL-6 signal transducergp130 in IL-1 1-mediated signal transduction. J Immunol. 1993, 151: 2555-2561
[60] Henderson B, Pettipher ER. Art hritogenic actions of recombinant IL-I and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in rive. Clin Exp Immunol, 1989. 75(2): 306-310
[61] 郭峰.血液免疫学研究[M].上海:第二军医大学出版社,1998,4
[62] Siegel I, Liu TL, GleicherN. The red cell Immune system. Lancet, 1981, 2: 8246
[63] 时庆,韩辉,韩振霞.红细胞免疫检测的临床评价[J].中国实验临床免疫,1999,10(3):145-149
[64] 陈国强,张德成.红细胞C3b受体研究的新进展[J].中国免疫学杂志,1991,(6):8
[65] 郭峰,钱宝华,张乐之.现代红细胞免疫学[M].上海:第二军医大学出版社,2002,1-113.
[66] 余曙光,郝亮,宋开源,等.艾灸对类风湿关节炎大鼠血清ICAM-1的影响[J].中国针灸,2002,22(10):690-692.
[67] Paleoog EM, Angiogenesis. aeritical process in the pathogenesis of RA arole for VEGF Br J Rheumatol, 1996, 35: 917
[68] 裴瑞卿.基质金属蛋白酶家族介绍[J].中国生物化学与分子生物学报,2001,17(1):1-6.
[69] 赵志玲.基质金属蛋白酶及其抑制剂与类风湿性关节炎的研究进展[J].解放军药学学报,2005,21,(1):54-56
[70] 任洁,齐义成.类风湿性关节炎与细胞凋亡[J].天津医药,2004,32(4):255
[71] 周静,周桂琴,肖诚,等.基质金属蛋白酶MAPKS途径在类风湿性关节炎发病中的作用[J].中国中医基础医学杂志,2004,10(6):78
[72] Clio R, BeatriceA, Jean M J, et al. Matrix metalloproteinase 3 serumlevels are correlated with diseaseactivity and predietelinieal responseinrhed matoidarthritis[J]. J Rheum, 2000, 27(4): 888.
[73] 柴可夫.类风湿性关节炎[M].北京:科学技术文献出版,2000年版,18-21
[74] 浅原弘嗣·他 诊断治疗,1997,85(4):608
[75] KoushiFujisawa. HiroshiAsahaia. Kazu yoshiOkamoto. etal Thera -Peutie effect of the anti-fas antibody on arlhritis in HTLV-1 tax. tlansgeniemiee. JCihlnvest1996, 98: 271-278
[76] LinZ. XuX, HsaHG etalCll-D C, AdTRAILcellgenethemPy inbi-h its hfiltration of Cll-reative Tcells andCll induced arthritisJClinInvest 2003, 11: 1332-1341
[77] MatsnoH, YudohK, NakazawaF, etal Antirheumatic effects of hu-manized an ti-Fas monoclonal antibody inhuman rheumatoidarlhritis/SCIDmousechiera Jrheumato12002, 29: 1609-1614
[78] Chin JE, Winterrowd GE, Krzesicki RF, et al. Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule-1 and HLA-class Ⅰ and class Ⅱ antigens in rheumatoid synovial fibroblasts. Arthritis Rheum, 1990, 33: 1776-1786.
[79] 张文.粘附分子在类风湿关节炎中的作用[J].中华风湿病学杂志,1998,2(1):51
[80] 梁文同,刘风珍,宋胜利,等.类风湿性关节炎(RA)患者血清可溶性细胞间粘附分子-1 测定与核素骨显像相关性研究[J].中华临床与卫生,2004,3(1):8-10
[81] Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease-Nat Med1995, 1: 27-34
[79] Clauss, M, M. Gerlach, H. Gerlach, et al. Vascular permeability factor, a tumor-derived ploypeptide that induces endothelial cells and monocyte procoagulant activity and promotes monocyte migration, J Exp Med 1990, 164: 470-477
[83] 敖桂珍,张玉彬,张奕华.新型非甾体抗炎药作用靶环氧酶-2研究进展[J].中国新药杂志,2001,10(7):492-496
[84] 张新梅.类风湿性关节炎免疫治疗研究进展[J].医学综述,2004,10(2):115-117
[85] 刘或,韩星海,孟济明等.生物制剂在类风湿关节炎中的应用[J].中华风湿病学杂志,2003,7(5):300-301
[86] 赵延红.生物制荆在RA治疗中的应用[J].陕西中医学院学报,2004,27(2):69
[87] 严桂民.类风湿关节炎的基因治疗[J].中国新医药,2003,2(8):47
[88] 鲍春德.类风湿性关节炎治疗的现状及展望[J].上海医学,2003,26(7):449
[89] 徐叔云,卞如濂.陈修药理实验方法学[M].北京:人民卫生出版社,1991,723
[90] 张钧田.现代药理实验方法[M].北京:北京医科大学中国协和医科大学联合出版社,1998,1383.
[91] 郭峰,张励力.用C3b致敏醉母菌测定血清免疫复合物[J].上海免疫学杂志,1982,2(2):32
[92] Jacobson PB, Borgan SJ, Wilcox D M et al. A new spin on an old model: In viva evaluation of sense progression by magnetic reso-nance imaging with respect to standard inflammatory parametersand histopathology in the adjuvant arthritic rat. Arth tis Rheum, 1999, 42(10): 2060-73
[93] 吕爱平.类风湿关节炎中西医结合应用基础研究[M].北京:中医古籍出版社,1999,23
[94] 王绪辉.肢体痹证的造模方法[J].上海中医药杂志,1986,(3):3-5
[95] Easset RE, Hildebrand AR, Angelo RA, et al. Measure merit of radiographic changes in adjuv ant-induced arthritis in its by quantitative image analysis. Arthritis Rjeurr, 1995, 38: 129
[96] 许赤多,戴冽,汤美安等.大鼠佐剂性关节炎的诱导及观察指标比较[J].中国免疫学杂志,2002,18(2):140-141
[97] 陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1993,第一版.
[98] 王一涛,杨奎,王家葵,等.羌活的药理学研究[J].中药药理与临床,1996(4):12-15.
[99] 万尧德,何光星,胡菊英,等.茵陈素解热作用的研究,药学通报[J].1987,22(10):590-593
[100] 田代华.实用中药辞典[M].北京:人民卫生出版社,2002.1279.
[101] 钱信忠.中国本草彩色图鉴[M].常用中药篇(上卷)北京:人民卫生出版社, 1995, 99,153,166,254
[102] 董丽萍.葛根对免疫机制的作用[J].中国药理学报,1998,19(4):339.
[103] 蔡仙德,谭剑萍.黄琴贰对小鼠体液免疫功能影响[J].南京铁道医学院学报,1995,14(3):151-153
[104] 中华人民共和国药政管理局.现代实用本草[M].北京:人民卫生出版社,1999,248
[105] 骆和生,罗鼎辉.免疫中药学[M].北京:北京医科大学、中国协和医科大学联合出版社,1999,281
[106] 陈兰英,陈奇.中药复方药理研究方法进展[J].中国实验方剂学杂志,1999,5(3):62-64.
[107] 贺新怀,席孝贤.中医药免疫学[M].北京:人民军医出版社,2002,40.
[108] CalvinoB, CrePon— Bernard MO, LeBars D. Parallel clinical and behavioural studies of adjuvant — induced arthritis in the rat: Possible relationship with, "chronic pain", Behavioural Brain Research, 1987, 24(1): 11-19
[109] Niki Y, Ya mada H, Seki S, et al. Macrophage and neutrophildomi-nant arthritis in human IL-1 alpha trans genic mice. J Clin Invest, 2001, 107: 1127-1135.
[110] Siegel, TheRedCellImmuneSystem[M]. Lancet, 1981, 2: 556.
[111] 刘景田,张洁.红细胞免疫学[M].西安:陕西科学技术出版社,1995,11
[112] 张乃峥.临床风湿病学[M].北京:人民卫生出版社,1997,129-130
[113] Gearing A, Newman F: Circulating adhesion molecules in disease. Immunology Today. 1999, 14: 506-512
[114] S AOKI, Soluble intercellular adhesion molecule- 1(ICAM-1)antigen in Patiente- with rheumatoid arthritis. Stand J Immunoi, 1993, 38: 485-90
[115] Fava RA, Olsen NJ, Spencer-Green G, Vascular permeability factor/endothelial growth factor(VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994, 180:341
[116] 王建华,吴岳篙,徐卫东,等.血管内皮生长因子在大鼠实验性关节炎模型中表达的动态观察[J].中华风湿病学杂志,2002,6(1):43.
[117] synovial, fibroblasts, that digests connective tissue matrix components. J BiolChen1986, 261: 142, 45-55
[118] Zucker S, Hymowitzm, Conner c, et al. Measurement of matrix metanlloproteinases andtissue in hibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. 1999, 878: 212-27
[119] Posthumus MD, Limburg PC, Westra J, etal. Serum matrix metalloproteinase 3 levels during treatment with sulfassalazine or combination of methotrexate and sulfasalazine in patientswith early rheumatoid arthritis. J Rheumatol, 2002, 29: 883-9
[120] Konttinen YT, AinolaM, VallealaH, et al.. Analysis of 16 different matrix metalloProtelnases (MMP-1 to MMP-20)in the synovial membrane: differeniProfilesintraumaandtheUInatOid artllritis Ann Rheum Dis 1999, 58: 691-7
[121] 蒋明,朱立平,林孝义.风湿病学(上册)[M].北京:科学出版社,1995,815-819
[122] Nakajima T, Aono Hjiasmuma TApoptosis and functional Fas antigen in rheumatoid artbtitiis synoviocytes. Arthritis Rleurm1995, 38, 485-491.
[123] 郭磊.细胞凋亡在自身免疫发病机制中的作用[J].国外医学免疫学分册,1999,22(1):17-21
[124] 郑勇,袁泉.细胞凋亡基因fas的研究进展[J].国外医学免疫学分册,1996,19(3):131-135
[125] 孙红胜,陈昀,庞新强,等.类风湿关节炎细胞凋亡研究进展[J].中华风湿病学杂志,2000,